Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hok Seon Kim

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|April 9, 2023
Antibody-guided proteases enable selective and catalytic degradation of challenging therapeutic targetsMatthew G Romei, Brandon Leonard, Ingrid Kim, et al.
Mabs|September 9, 2016
Evading pre-existing anti-hinge antibody binding by hinge engineeringHok Seon Kim, Ingrid Kim, Linda Zheng, et al.
Biochemistry|November 16, 2005
Isolation and characterization of the B-cell marker CD20James A Ernst, Hong Li, Hok Seon Kim, et al.
Plos One|May 8, 2012
Translation levels control multi-spanning membrane protein expressionHok Seon Kim, James A Ernst, Cecilia Brown, et al.
Protein Engineering, Design & Selection : PEDS|October 7, 2017
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screeningHok Seon Kim, Diana Ronai Dunshee, Angie Yee, et al.
Molecular Pharmaceutics|August 18, 2018
Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection ProcessAnkai Xu, Hok Seon Kim, Samarkand Estee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methodsM Teresa Pisabarro, Beatrice Leung, Mandy Kwong, et al.
British Journal of Pharmacology|October 2, 2023
A novel, label-free, pre-equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cellsEric M Janezic, Alexander Doan, Elaine Mai, et al.
Molecular Pharmaceutics|June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched FabWhitney Shatz, Philip E Hass, Mary Mathieu, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|April 9, 2023
Antibody-guided proteases enable selective and catalytic degradation of challenging therapeutic targetsMatthew G Romei, Brandon Leonard, Ingrid Kim, et al.
Mabs|September 9, 2016
Evading pre-existing anti-hinge antibody binding by hinge engineeringHok Seon Kim, Ingrid Kim, Linda Zheng, et al.
Biochemistry|November 16, 2005
Isolation and characterization of the B-cell marker CD20James A Ernst, Hong Li, Hok Seon Kim, et al.
Plos One|May 8, 2012
Translation levels control multi-spanning membrane protein expressionHok Seon Kim, James A Ernst, Cecilia Brown, et al.
Protein Engineering, Design & Selection : PEDS|October 7, 2017
Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screeningHok Seon Kim, Diana Ronai Dunshee, Angie Yee, et al.
Molecular Pharmaceutics|August 18, 2018
Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection ProcessAnkai Xu, Hok Seon Kim, Samarkand Estee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methodsM Teresa Pisabarro, Beatrice Leung, Mandy Kwong, et al.
British Journal of Pharmacology|October 2, 2023
A novel, label-free, pre-equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cellsEric M Janezic, Alexander Doan, Elaine Mai, et al.
Molecular Pharmaceutics|June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched FabWhitney Shatz, Philip E Hass, Mary Mathieu, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Pageof 2